title: Is the second line data on the use of docetaxel in non-small cell lung cancer reproducible?
authors.forename: Kate
authors.initials: K
authors.lastname: Sumpter
authors.forename: Catherine
authors.initials: C
authors.lastname: Harper-Wynne
authors.forename: Cheng
authors.initials: C
authors.lastname: Yeoh
authors.forename: Sanjay
authors.initials: S
authors.lastname: Popat
authors.forename: Sue
authors.initials: S
authors.lastname: Ashley
authors.forename: Alison
authors.initials: A
authors.lastname: Norton
authors.forename: Mary
authors.initials: M
authors.lastname: O'Brien
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D000077143:Docetaxel; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D011446:Prospective Studies; D015996:Survival Rate; D043823:Taxoids / Q000627:therapeutic use*
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D043823:Taxoids; D000077143:Docetaxel